Huberman separates nicotine's real cognitive benefits from the deadly delivery devices, and details the science of quitting smoking and vaping.

Andrew Huberman: Stanford professor of neurobiology and ophthalmology and host of the Huberman Lab Podcast. Solo episode drawing on his own early research into nicotine and brain development.
This solo episode explains how nicotine works in the brain and body by binding nicotinic acetylcholine receptors, boosting dopamine, acetylcholine, and epinephrine to enhance focus, mood, and alertness. Huberman insists nicotine itself must be separated from its delivery devices: smoking, vaping, dipping, and snuffing damage endothelial cells and contain carcinogens that drive cancer, stroke, and reduced lifespan. He covers why nicotine suppresses appetite, why vaping resembles crack cocaine in its rapid dopamine kinetics, and why it is so addictive. The back half details evidence-based methods to quit, including clinical hypnosis, Bupropion, and nicotine replacement therapy, plus the homeostasis science behind brutal first-week withdrawal.
“Alpha GPC taken in 300 milligram form 10 to 30 minutes before a about of cognitive work or a about of physical work will increase your focus”— Andrew Huberman
Dr. Anna Lembke
“Also check out her absolutely phenomenal and indeed important book "Dopamine Nation", which touches on some of this as well.”— Andrew Huberman
Nicorette
“But when people ingest nicotine acutely, and let's say they do that by Nicorette patch or by toothpick dipped in nicotine, it will have some of these same effects”— Andrew Huberman
“One of the main ones that's received a lot of attention in recent years is Bupropion, sometimes referred to by its commercial name Wellbutrin.”— Andrew Huberman